140 related articles for article (PubMed ID: 3079320)
1. The carcinoid syndrome: a treatable malignant disease.
Kvols LK
Oncology (Williston Park); 1988 Feb; 2(2):33-41. PubMed ID: 3079320
[TBL] [Abstract][Full Text] [Related]
2. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon.
Janson ET; Oberg K
Acta Oncol; 1993; 32(2):225-9. PubMed ID: 7686765
[TBL] [Abstract][Full Text] [Related]
3. Hepatic artery embolisation--new approach for treatment of malignant carcinoid syndrome.
Jermendy G; Kónya A; Kárpáti P
Dtsch Z Verdau Stoffwechselkr; 1986; 46(2):130-6. PubMed ID: 2424713
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; Hanley JA
Cancer Clin Trials; 1979; 2(4):327-34. PubMed ID: 93982
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of carcinoid syndrome in two cases of bronchial carcinoid].
Katakami N; Matsumoto H; Ishihara K; Umeda B
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1313-8. PubMed ID: 8583728
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
[TBL] [Abstract][Full Text] [Related]
7. [Management of digestive system carcinoid tumors and carcinoid syndrome].
Mondragón Sánchez RJ; Castillero Pinilla C; Saldívar Moreno C; Oñate Ocaña LF; Ruiz Molina JM; Aiello Crocifoglio V
Rev Gastroenterol Mex; 1998; 63(4):204-10. PubMed ID: 10319670
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
Deguchi H; Deguchi K; Tsukada T; Murashima S; Iwasaki E; Tsuda M; Kobayashi T; Shirakawa S
Intern Med; 1994 Feb; 33(2):100-2. PubMed ID: 7517229
[TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
10. [Carcinoid tumors].
Tóth M; Prónai L; Németh AM; Tulassay Z
Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867
[TBL] [Abstract][Full Text] [Related]
11. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG;
J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors.
Frank M; Klose KJ; Wied M; Ishaque N; Schade-Brittinger C; Arnold R
Am J Gastroenterol; 1999 May; 94(5):1381-7. PubMed ID: 10235222
[TBL] [Abstract][Full Text] [Related]
13. Hepatic artery embolization for treatment of patients with metastatic carcinoid tumors: a commentary.
Norton JA; Kerlan RK
Cancer J; 2003; 9(4):241-3. PubMed ID: 12967132
[No Abstract] [Full Text] [Related]
14. Malignant pancreatic carcinoid tumour.
Zarina AL; Hamidah A; Zulkifli SZ; Zulfiqar MA; Jamal R
Singapore Med J; 2007 Dec; 48(12):e320-2. PubMed ID: 18043827
[TBL] [Abstract][Full Text] [Related]
15. Carcinoid encephalopathy: A single entity or a spectrum of different disorders?
Lapeire LD; Tansens A; Lemmens GM; Van Belle SJ
Acta Oncol; 2010; 49(2):268-70. PubMed ID: 20001498
[No Abstract] [Full Text] [Related]
16. Revisiting C.G. Moertel's land of small tumors.
Kvols LK
J Clin Oncol; 2008 Nov; 26(31):5005-7. PubMed ID: 18838695
[No Abstract] [Full Text] [Related]
17. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors.
Eriksson BK; Larsson EG; Skogseid BM; Löfberg AM; Lörelius LE; Oberg KE
Cancer; 1998 Dec; 83(11):2293-301. PubMed ID: 9840528
[TBL] [Abstract][Full Text] [Related]
18. Metastatic carcinoid tumors and the carcinoid syndrome. A selective review of chemotherapy and hormonal therapy.
Kvols LK
Am J Med; 1986 Dec; 81(6B):49-55. PubMed ID: 2432781
[TBL] [Abstract][Full Text] [Related]
19. [Carcinoid syndrome: advances in diagnosis and treatment].
Ortiz V; Nicolás D; Pastor MA; Olaso V; Berenguer J
Rev Esp Enferm Dig; 1999 Jan; 91(1):61-9. PubMed ID: 10089788
[TBL] [Abstract][Full Text] [Related]
20. [Carcinoid tumor with revealed by skin manifestation].
Reichert S; Truchetet F; Cuny JF; Grandidier M
Ann Dermatol Venereol; 1994; 121(6-7):485-8. PubMed ID: 7535513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
